X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (58613) 58613
Newsletter (2332) 2332
Book Chapter (195) 195
Magazine Article (184) 184
Dissertation (123) 123
Newspaper Article (67) 67
Publication (31) 31
Conference Proceeding (30) 30
Book / eBook (12) 12
Book Review (7) 7
Web Resource (5) 5
Government Document (4) 4
Streaming Video (2) 2
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35857) 35857
cyclosporine (24961) 24961
male (22963) 22963
female (18861) 18861
animals (15853) 15853
transplantation (15785) 15785
adult (14014) 14014
cyclosporine - therapeutic use (12499) 12499
middle aged (12340) 12340
immunosuppressive agents - therapeutic use (11549) 11549
surgery (10816) 10816
cyclosporine-a (10722) 10722
immunology (10656) 10656
cyclosporine - pharmacology (8217) 8217
rats (7730) 7730
pharmacology & pharmacy (6660) 6660
cyclosporine - administration & dosage (5741) 5741
treatment outcome (5503) 5503
adolescent (5489) 5489
aged (5289) 5289
time factors (5181) 5181
cyclosporine - adverse effects (5138) 5138
tacrolimus (5049) 5049
immunosuppressive agents - adverse effects (5034) 5034
immunosuppression (4684) 4684
kidney transplantation (4678) 4678
immunosuppressive agents - administration & dosage (4671) 4671
drug therapy, combination (4457) 4457
child (4448) 4448
mice (4417) 4417
therapy (4237) 4237
immunosuppressive agents - pharmacology (4158) 4158
retrospective studies (4057) 4057
recipients (3957) 3957
urology & nephrology (3622) 3622
follow-up studies (3582) 3582
kidney transplantation - immunology (3469) 3469
biochemistry & molecular biology (3341) 3341
graft rejection - prevention & control (3167) 3167
tacrolimus - therapeutic use (3055) 3055
research (3038) 3038
dose-response relationship, drug (2970) 2970
expression (2960) 2960
hematology (2946) 2946
risk factors (2898) 2898
transplantation, homologous (2887) 2887
pharmacokinetics (2761) 2761
cyclosporine a (2747) 2747
analysis (2719) 2719
cyclosporin a (2588) 2588
child, preschool (2571) 2571
oncology (2489) 2489
calcineurin inhibitors (2395) 2395
cells, cultured (2342) 2342
cyclosporine - pharmacokinetics (2311) 2311
immunosuppressive agents - pharmacokinetics (2263) 2263
mycophenolic acid - analogs & derivatives (2204) 2204
rejection (2178) 2178
kidneys (2163) 2163
cyclosporine - blood (2161) 2161
drugs (2143) 2143
disease (2129) 2129
apoptosis (2086) 2086
graft survival (2059) 2059
dermatology (2044) 2044
rats, sprague-dawley (2028) 2028
cell biology (2008) 2008
prospective studies (1997) 1997
fk506 (1995) 1995
cells (1958) 1958
calcineurin (1957) 1957
children (1944) 1944
tacrolimus - pharmacology (1937) 1937
azathioprine - therapeutic use (1906) 1906
health aspects (1896) 1896
inhibition (1882) 1882
sirolimus (1879) 1879
medicine, general & internal (1874) 1874
kidney transplantation - physiology (1866) 1866
pediatrics (1848) 1848
immunosuppressive agents (1842) 1842
mycophenolate-mofetil (1818) 1818
rats, wistar (1795) 1795
drug interactions (1780) 1780
gastroenterology & hepatology (1764) 1764
administration, oral (1756) 1756
care and treatment (1750) 1750
p-glycoprotein (1685) 1685
renal-transplantation (1679) 1679
mycophenolic acid - therapeutic use (1671) 1671
activation (1665) 1665
efficacy (1650) 1650
kidney transplantation - adverse effects (1641) 1641
creatinine - blood (1638) 1638
immunosuppressive agents - blood (1638) 1638
liver transplantation (1633) 1633
nephrotoxicity (1633) 1633
young adult (1588) 1588
graft survival - drug effects (1574) 1574
liver (1563) 1563
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57844) 57844
German (984) 984
French (941) 941
Japanese (769) 769
Spanish (594) 594
Chinese (380) 380
Korean (241) 241
Portuguese (226) 226
Italian (190) 190
Russian (168) 168
Polish (152) 152
Czech (61) 61
Turkish (46) 46
Hungarian (36) 36
Dutch (30) 30
Danish (15) 15
Ukrainian (14) 14
Finnish (13) 13
Serbian (13) 13
Norwegian (12) 12
Croatian (11) 11
Romanian (9) 9
Slovak (9) 9
Persian (8) 8
Hebrew (5) 5
Swedish (4) 4
Lithuanian (3) 3
Afrikaans (1) 1
Arabic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 359, Issue 5, pp. 473 - 481
Journal Article
European journal of clinical pharmacology, ISSN 1432-1041, 2014, Volume 70, Issue 6, pp. 685 - 693
Tacrolimus (Tac) and cyclosporine (CsA) are mainly metabolized by CYP3A4 and CYP3A5. Several studies have demonstrated an association between the CYP3A5... 
CYP3A | POR | Biomedicine | Calcineurin inhibitors | Kidney recipients | Pharmacology/Toxicology | Pharmacokinetics | PPARA | CYP3A4-ASTERISK-22 | GENOTYPE | POLYMORPHISM | CLINICAL PHARMACOKINETICS | DOSE REQUIREMENTS | CYTOCHROME-P450 OXIDOREDUCTASE | IN-VITRO | P450 OXIDOREDUCTASE | IMPACT | PHARMACOLOGY & PHARMACY | MIDAZOLAM | NADPH-Ferrihemoprotein Reductase - genetics | Humans | Immunosuppressive Agents - pharmacokinetics | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cyclosporine - blood | Dose-Response Relationship, Drug | Young Adult | Immunosuppressive Agents - blood | Cytochrome P-450 CYP3A - genetics | Cyclosporine - pharmacokinetics | Adult | Female | Retrospective Studies | Real-Time Polymerase Chain Reaction | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Tacrolimus - blood | Gene Frequency | Genotype | PPAR alpha - genetics | Kidney Transplantation | Tacrolimus - pharmacokinetics | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Analysis of Variance | Polymorphism, Restriction Fragment Length | Cyclosporine - administration & dosage | Aged | Kidneys | Tacrolimus | Cytochrome P-450 | Genetic research | Physiological aspects | Drugstores | Organ transplant recipients | Transplantation | Cyclosporine | Genetics | Pharmacology | Transplants & implants | Pharmacogenetics
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9768, pp. 837 - 847
Journal Article
International journal of nanomedicine, ISSN 1176-9114, 2014, Volume 9, pp. 4991 - 4999
Journal Article
Journal Article
International journal of nanomedicine, ISSN 1178-2013, 2018, Volume 13, pp. 1225 - 1240
Background: Colon-targeted oral nanoparticles (NPs) have emerged as an ideal, safe, and effective therapy for ulcerative colitis (UC) owing to their ability to... 
Cyclosporine A | Sustained and pH-sensitive release | Colon-targeted nanoparticles | Ulcerative colitis | LIPID NANOPARTICLES | cyclosporine A | DRUG-DELIVERY | SEVERE ULCERATIVE-COLITIS | INTRAVENOUS CYCLOSPORINE | NANOSCIENCE & NANOTECHNOLOGY | colon-targeted nanoparticles | sustained and pH-sensitive release | MOUSE MODELS | INFLAMMATORY-BOWEL-DISEASE | POLYMERIC NANOPARTICLES | THERAPY | PH-SENSITIVE NANOPARTICLES | PHARMACOLOGY & PHARMACY | ulcerative colitis | ORAL DELIVERY | Body Weight | Methylmethacrylates - chemistry | Nanoparticles - chemistry | Immunosuppressive Agents - therapeutic use | Drug Carriers - administration & dosage | Colitis - pathology | Drug Delivery Systems | Colitis - chemically induced | Inflammation Mediators - metabolism | Colitis - drug therapy | Lactic Acid - chemistry | Cytokines - metabolism | Macrophages - pathology | Administration, Oral | Colon - pathology | Nanoparticles - ultrastructure | Treatment Outcome | Mice, Inbred ICR | Particle Size | Cyclosporine - therapeutic use | Animals | Polyglycolic Acid - chemistry | Cyclosporine - administration & dosage | Drug Liberation | Macrophages - drug effects | Nanoparticles - administration & dosage | Hydrogen-Ion Concentration | Peroxidase - metabolism | Nanoparticles | Analysis | Gastrointestinal system | Cyclosporine | Polymers | Scanning devices | Patient compliance | Inflammatory bowel disease | Drug delivery systems | Colon | Rodents
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 11, pp. 1021 - 1031
Patients with acute STEMI undergoing PCI were assigned to cyclosporine or placebo. No significant between-group difference was seen in the rate of death,... 
HEART | MEDICINE, GENERAL & INTERNAL | MITOCHONDRIAL PERMEABILITY TRANSITION | PERCUTANEOUS CORONARY INTERVENTION | INJECTION | REPERFUSION INJURY | SIZE | PORE | ISCHEMIA | CARDIOPROTECTION | ASPIRATION | Enzyme Inhibitors - adverse effects | Injections, Intravenous | Double-Blind Method | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Male | Combined Modality Therapy | Enzyme Inhibitors - administration & dosage | Cyclophilins - antagonists & inhibitors | Myocardial Infarction - therapy | Myocardial Infarction - drug therapy | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Electrocardiography | Female | Aged | Heart Failure - epidemiology | Ventricular Remodeling - drug effects | Percutaneous Coronary Intervention | Care and treatment | Usage | Angiography | Heart enlargement | Dosage and administration | Cyclosporine | Heart attack | Occlusion | Myocardial infarction | Heart | Cerebral infarction | Heart attacks | Intravenous administration | Cyclosporins | Angioplasty | Body weight | Coronary artery | Clinical trials | Angina | Patients | Clinical outcomes | Reperfusion | Ventricle | Drug therapy | Heart diseases | Pharmaceuticals | Life Sciences | Bioengineering | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article